EMA confirms possible link between J&J COVID vaccine and unusual blood clots
The European Medicines Agency’s (EMA’s) safety committee (PRAC) has concluded that a warning about unusual blood clots with low blood platelets should be added...
Moderna jab marks new milestone in NHS vaccination programme
A third COVID-19 vaccine has started being rolled out across more than 20 sites, including Reading’s Madejski Stadium and the Sheffield Arena, as the...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
Twice weekly rapid COVID-19 testing to be available to everyone in England
Access to twice weekly, free, regular, rapid coronavirus (COVID-19) testing from 9 April for everyone in England, the Government has announced. Everyone in England,...
GSK to support manufacture of Novavax’ COVID-19 vaccine
GlaxoSmithKline (GSK) has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up to 60 million...
New lateral flow device distribution service announced for pharmacies
A new advanced service – the NHS community pharmacy COVID-19 lateral flow device distribution service – has been added to the NHS Community Pharmacy Contractual Framework (CPCF). The service,...
UK Health Security Agency launched to deal with future threats
A new UK Health Security Agency (UKHSA) has launched to plan for, prevent and respond to future external health threats such as infectious diseases. The...
The future of digital healthcare
Building on the huge progress the NHS made during 2020, Gianpiero Celino, Clinical Director, Cegedim Healthcare Solutions, outlines a vision for the future of...
AstraZeneca releases updated US trial data on COVID-19 vaccine
AstraZeneca has released updated information about its COVID-19 vaccine following concern expressed by the Data and Safety Monitoring Board (DSMB) about initial data from...
MSD’s pembrolizumab added to NHSE COVID interim treatment list
MSD has reached an agreement with NHS England to make pembrolizumab available in England for eligible patients with metastatic MSI-H/dMMR colorectal cancer as an...
Latest articles
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials
The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Expand and evolve – when specialist services meet
Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...
NHS launches £160m initiative to tackle waiting lists
The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials
The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Chiesi launches new virtual learning and support platform for respiratory nurses
A new education platform that brings together nurses on an online community has launched to coincide with International Nurses Day 2021. Chiesi Limited has launched...
NHS launches £160m initiative to tackle waiting lists
The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...
Expand and evolve – when specialist services meet
Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...